Art

J-GLOBAL ID：201802253217404827   Reference number：18A0730849

腎疾患診療の未来 最新知見のエッセンシャル 腎疾患の新たな治療の可能性 トルバプタンの腎疾患治療への応用

Author (3)： MOCHIZUKI TOSHIO (東京女医大 多発性嚢胞腎病態研究部門) ,  AOYAMA YUMI (東京女医大 医 内科学第四(腎臓内科)) ,  MAKABE SHIHO (東京女医大 医 内科学第四(腎臓内科))
Material： 診断と治療  (Diagnosis and Treatment)
Volume： 106  Issue： 4  Page： 484-490  Publication year： Apr. 01, 2018 
JST Material Number： Z0941A  ISSN： 0370-999X  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *diuretic ,...
Semi thesaurus term： Polycystic Kidney, Autosomal Dominant

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0730849&from=J-GLOBAL&jstjournalNo=Z0941A") }}

JST classification (3)： Clinical application of drugs acting on urinary system  (GW11020C) ,  Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (1)： OPC-41061

Reference (16)：

• Irazabal MV, et al.:Imaging classification of autosomal dominant polycystic kidney disease:a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26:160-172, 2015
• Torres VE, et al.:Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407-2418, 2012
• Torres VE, et al.:Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage:Results from the TEMPO 3:4 Trial. Clin J Am Soc Nephrol 11:803-811, 2016
• Muto S, et al.:The effect of tolvaptan on autosomal dominant polycystic kidney disease patients:a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clin Exp Nephrol 19:867-877, 2015
• Torres VE, et al.:Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease:the TEMPO 4:4 Trial. Nephrol Dial Transplant 32:1262, 2017

Terms in the title (7)： 腎疾患 ,  診療 ,  未来 ,  治療 ,  可能性 ,  トルバプタン ,  応用